EX-23.1 5 tv485536_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

Synthetic Biologics, Inc.

Rockville, MD

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-180562, 333-188219, 333-156973, 333-206267, 333-207327, 333-206266, 333-203323 and 333-203322) and Form S-8 (Nos. 333-192355, 333-170858, 333-148764, 333-206268, 333-213388 and 333-203322) of our reports dated February 22, 2018, relating to the consolidated financial statements and the effectiveness of Synthetic Biologics, Inc.’s Internal Control over Financial Reporting, which appear in this Form 10-K. Our report on the consolidated financial statements contains an explanatory paragraph regarding the Company's ability to continue as a going concern.

/s/ BDO USA, LLP |

BDO USA, LLP

February 22, 2018